The Nitrile Gloves Market To Recede With A CAGR Of 24%

Posted by Ashish on March 26th, 2021

Pharmaceuticals and biotechnology companies are outsourcing specific services from the early stages of drug development to biological contract manufacturing organizations to reduce drug manufacturing costs. Outsourcing increases drug manufacturing efficiency and facilitates flexible operational capabilities, which is expected to immensely boost biologics contract manufacturing demand.

Rising prevalence of chronic and lifestyle diseases is also anticipated to propel biologics contract manufacturing demand. Besides, continuous focus by manufacturers toward adopting technologically-advanced systems to manufacture novel biologics is also expected to accelerate the demand for biologics contract manufacturing over the forecast period.

Planning Forward? Access Sample Of Biologics Contract Manufacturing Demand Market Report! https://www.persistencemarketresearch.co/samples/31928

Companies covered in Biologics Contract Manufacturing Demand Market Report

• BioXcellence (Boehringer Ingelheim GmbH)
• Lonza Group AG
• Samsung Biologics Co. Ltd.
• Fujifilm Diosynth Biotechnologies (FUJIFILM Holdings)
• AbbVie Contract Manufacturing (AbbVie Inc.)
• WuXi Biologics (Cayman) Inc.
• Patheon N.V. (Thermo Fisher Scientific Inc.)
• Emergent BioSolutions Inc.
• AGC Biologics
• Ajinomoto Bio-Pharma (Ajinomoto Co., Inc.)
• Avid Bioservices, Inc.
• KBI Biopharma (JSR Life Sciences (JLS))
• Catalent Inc.
• Abzena Plc.